Filing Details
- Accession Number:
- 0001209191-23-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-03 06:00:16
- Reporting Period:
- 2022-12-29
- Accepted Time:
- 2023-01-03 06:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 342037594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789822 | B. Scott Brown | C/O Tracon Pharmaceuticals, Inc. 4350 La Jolla Village Drive, Suite 800 San Diego CA 92122 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-29 | 3,500 | $1.49 | 21,628 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2022.
Billionaire Hedge Funds
